Clinical Management of Suspected or Confirmed COVID-19 Disease Version 5 (24 August 2020)

Clinical Management of Suspected or Confirmed COVID-19 Disease Version 5 (24 August 2020)

Clinical Management of Suspected or Confirmed COVID-19 Disease Version 5 (24 August 2020)

These guidelines describe the clinical management of cases of COVID-19 disease, including clinical care in and outside of health facilities, and are intended for use in both public had private sectors. The National Department of Health is committed to providing regular updates for guidelines, as knowledge regarding strategies to address COVID-19 develop both globally and in South Africa. This version of the guidelines provides additional information on the management of COVID-19 including updated guidance on drug therapy and respiratory support, including provision of high flow nasal oxygen. A section on provision of palliative care to patients with COVID-19 disease has also been added.

The guidelines are presented as ten modules in order to facilitate and expedite updating of individual sections in future:

  1. Epidemiology and clinical characteristics
  2. Testing
  3. Management of the patient with asymptomatic or mild disease
  4. Respiratory support for hospitalised COVID-19 patients
  5. Drug therapy
  6. Palliative care of patients with COVID-19
  7. Special populations: children, newborns, pregnant and breastfeeding women, and people living with HIV
  8. De-isolation and return to work
  9. Infection prevention and control (IPC)
  10. Recording and reporting
Type
Guides/Guidelines
Topic
Communicable Diseases
Language
English
Publisher
National Department of Health
Year
2020
Author
National Department of Health